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Background: Atypical pathogens such as Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella
pneumophila are increasingly recognized as important causes of community acquired pneumonia (CAP) worldwide.
Such etiological data for Vietnam is scarce and clinical doctors lack accurate information on which to base their
diagnosis and treatment of pneumonia. This study identifies the prevalence and risk factors of severe community
acquired pneumonia due to these atypical pathogens (severe-ApCAP) in children aged 1–15 years with CAP in a
pediatric hospital in Hanoi, Vietnam.
Methods: 722 hospitalized children with CAP were recruited for detecting those atypical pathogens, using
multiplex PCR and ELISA. Clinical and epidemiological data were collected. Multivariate logistic-regression analyses
were performed to evaluate the associations of potential risk factors with severe-ApCAP.
Results: Among 215 atypical pathogen-positive CAP cases, 45.12% (97/215) were severe-ApCAP. Among the
severe-ApCAP group, 55.67% (54/97) cases were caused by pure atypical pathogens and 44.33% (43/97) resulted
from a co-infection with typical respiratory pathogens. M. pneumoniae was the most common, with 86.6% cases
(84/97) in the severe-ApCAP group, whereas C. pneumoniae and L. pneumophila were less frequent (6.19% and
7.22%, respectively). The highest rate of severe-ApCAP was in children younger than two years (65.98%). The
differences related to age are statistically significant (P = 0.008).
The factors significantly associated with severe-ApCAP were age (OR = 0.84, 95% CI = 0.75-0.93, P = 0.001),
co-infection with typical bacteria (OR = 4.86, 95% CI = 2.17-10.9, P < 0.0001), co-infection with respiratory viruses
(OR = 4.36, 95% CI = 1.46-13.0, P = 0.008), respiratory/cardiac system malformation (OR = 14.8, 95% CI = 1.12 -196,
P = 0.041) and neonatal pneumonia (OR = 11.1, 95% CI = 1.06 -116, P = 0.044).
Conclusions: Severe-ApCAP presented at a significant rate in Vietnamese children. More than 50% of severe-ApCAP
cases were associated with pure atypical pathogen infection. M. pneumoniae appeared most frequently. The highest
rate of severe-ApCAP was in children younger than two years. Younger age and co-infection with typical bacteria
or viruses were the most significant risk factors, while respiratory/cardiac system malformation and neonatal
pneumonia were additional potential risk factors, associated with severe-ApCAP in Vietnamese children.
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Worldwide, pneumonia is a leading cause of child death,
killing 6.6 million children under the age of five years in
2012 [1]. In Vietnam, community-based studies suggest
that every child younger than five years suffers 5 to 8 ep-
isodes of acute respiratory infections annually [2], while
hospital-based investigations indicate that 35-50% of all
pediatric patients are hospitalized due to pneumonia.
The Vietnamese Ministry of Health has reported that
each year 4000 children younger than 5 years die from
pneumonia in Vietnam [3].
Atypical pathogens including M. pneumoniae, C. pneu-
moniae, and L. pneumophila cause mild, moderate or se-
vere acute respiratory tract infections in children. These
pathogens are increasingly recognized as important causes
of pneumonia in many countries, but their role in Vietnam
has not been well documented. This could diminish the ef-
fectiveness of the general guidelines for treatment of acute
respiratory tract infections in Vietnamese children. Prior to
2012, only antibiotics of beta-lactam group which do not
naturally affect those atypical pathogens were included in
the guidelines for pneumonia treatment in children, notably
omitting the macrolide group (erythromycin, clarithromy-
cin, azithromycin), which is the first-choice therapeutic
agent against atypical pathogen infections in both children
and adults. Such incorrect treatment could result in serious
pneumonia requiring hospitalization.
Investigations of typical pathogens causing severe pneu-
monia in children have not included atypical pathogens be-
cause it is difficult and not relevant for clinical treatment to
detect them by culture methods. This unique study used
multiplex polymerase chain reaction (PCR) as the principal
method and enzyme-linked immunosorbent assay (ELISA)-
based specific IgM antibody for determination of these
three atypical pathogens aimed at investigating prevalence
of and risk factors for severe community-acquired pneumo-
nia (CAP) caused by M. pneumoniae, C. pneumoniae and
L. pneumophila in hospitalized children with CAP aged
1–15 years old in Vietnam.
Methods
Study population
Seven hundred twenty-two hospitalized children aged 1
to 15 years with community-acquired pneumonia were
recruited for the prospective hospital-based study at the
National Hospital of Pediatrics (NHP), Hanoi. This study
was conducted from July 2010 through March 2012,
with the approval of Research Ethics Committee, NHP,
Hanoi, Vietnam and the agreement from the parents of
these patients to participate in the study.
The definition of atypical pathogen - positive CAP
(ApCAP) case we used was the following: 1) patients
with clinical symptoms of pneumonia, confirmed byradiography and 2) presence of M. pneumoniae and/or
C. pneumoniae and/or L. pneumophila, detected in broncho-
alveolar lavages, identified by multiplex PCR and ELISA-
based specific IgM antibodies against M. pneumoniae, or
C. pneumoniae, or L. pneumophila in one of paired sera.
Criteria for classification of severe pneumonia in children
Was according to Pediatric Infectious Diseases Society (PIDS)
and the Infectious Diseases Society (IDS) of America [4]:
+ Major criteria (≥1 major criteria): invasive
mechanical ventilation; fluid refractory shock;
hypoxemia requiring fraction of inspired oxygen (FiO2)
greater than inspired concentration or flow feasible in
general care area.
+ Minor criteria (≥2 minor criteria): respiratory rate
higher than WHO classification for age; apnoea;
increased labored breathing; the ratio between partial
pressure of arterial oxygen (PaO2) and fraction of
inspired oxygen (FiO2) < 250; multilobar infiltrates (≥2
lobes); Pediatric Early Warning Signs (PEWS) score > 6;
altered mental status; hypotension; presence of effusion.
Sample size
The sample size of 710 was calculated (Additional file 1)
to estimate the prevalence of ApCAP of 23.5% within
0.032 with 95% confidence interval, considering the fol-
lowing parameters: α = 0.05, β = 0.2, and nonresponsive
rate = 5% [5].
Data collection
At the time of admission, systematic recordings were made
for each patient, including medical history, the underlying
respiratory symptoms and physical examination. Epidemio-
logical information was collected by interviewing each pa-
tient’s parent using a standardized questionnaire.
Chest X-ray
After a complete physical examination, chest X-rays
were taken. Two senior radiologists read the X-rays and
agreed on the conclusion.
Microbiological diagnosis
Enrolled patients were investigated for microbiological
diagnosis based on respiratory specimens (broncho-al-
veolar lavages) and two serum samples collected at ad-
mission and again after three weeks.
The laboratory tests were performed on blood speci-
mens taken to count leukocytes (WBC), C-reactive protein
(CRP) and for the detection of IgM antibodies against M.
pneumoniae, C. pneumoniae and/or L. pneumophila.
Broncho-alveolar lavages were used for detection of
M. pneumoniae, C. pneumoniae and L. pneumophila spe-
cific DNA by multiplex PCR.
Table 1 Proportion of patients with atypical pathogen
positive community - acquired pneumonia on the basis
of PCR and serological findings
Total number of enrolled patients with community acquired
pneumonia: 722












M. pneumoniae 9 42 139 190
C. pneumoniae 0 7 6 13
L. pneumophila 0 1 11 12
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PCR) was applied to determine the presence of viral re-
spiratory pathogen co-infection (adenovirus, respiratory
syncytial virus (RSV), rhinovirus, influenza A & B, para-
influenza 1–3 viruses) using the method of Robin
Brittain-Long et al. [6]. For viral RNA extraction we
used QIAamp Viral RNA Mini kit (QIAGEN Strasse 1,
40724 Hilden, Germany, Cat No. 52906). The RT-PCR
was done using Kit SuperScript III One-Step Kit
(Invitrogen Co., 3175 Staley Road, Grand Island, NY
14072, USA). We used the quantitative culture method to
detect typical bacterial respiratory pathogens such as
Haemophilus influenzae, Streptococcus pneumoniae, and
Moraxella catarrhalis in bronchoalveolar lavages and the
results were analyzed according to the published
method [7].
Detection of atypical pneumonia pathogens
Multiplex polymerase chain reaction
Broncho-alveolar lavages were kept at −70°C. At test time,
all sample volumes were thawed, mixed well, and centri-
fuged at 15,000 rpm for 10 min at room temperature.
Most of the supernatant was discarded and 200 μl of the
pellets was used for DNA extraction with QIAamp DNA
Mini Kit (QIAGEN Strasse 1, 40724 Hilden, Germany, cat
#51304) according to the manufacturer’s instructions.
M. pneumoniae, C. pneumoniae and L. pneumophila
DNA were detected by the Multiplex PCR method with
primer sets for amplification of the P1 gene for M. pneu-
moniae (MP-F: 5’- AACTATGTTGGTGTATGACCAG
TAC-3’ and MP-R: 5’- ACCTTGACTGGAGGCCGTTA-
3’) [8]; the major outer membrane protein gene for C.
pneumonia (CP-F:5’-GTTGTTCATGAAGGCCTACT-3’
and CP-R: 5’-CGTGTCGTCCAGCCATTTTA-3’) [9] and
macrophage infectivity potentiator gene for L. pneumophila
(mip F2: 5’- GCATTGGTGCCGATTTGG-3’ and mip R2:
5’- GCTTTGCCA TCAAATCTTTCTGAA-3’) [10]. The
details of the multiplex PCR applied to detect atypical
pneumonia pathogens are presented in Additional file 2.
Enzyme-linked immunosorbent assay (ELISA)
Two serum samples were collected from each patient, the
first on admission and the second after 3 weeks, and stored
at – 20°C until testing. Titers of specific IgM were evalu-
ated using commercial test kits for M. pneumoniae ELISA-
IgM (Mycoplasma pneumoniae ELISA IgM Ref # M1002),
C. pneumoniae ELISA-IgM (Chlamydophila pneumoniae
ELISA IgM Ref # M1007) and L. pneumophila ELISA-IgM
(Legionella pneumophila ELISA IgM Ref # M1000) Kits
(Vircell S.L, 18016 Granada, Spain), respectively, following
the manufacturer’s instructions. The result was recorded
as positive when the IgM antibody (Ab) index was greater
than 11, as equivocal between 9 and 11, and as negative
if under 9.Statistical analysis
Frequencies of categorical variables were compared by Fisher’s
exact test when appropriate. Binary logistic regression ana-
lysis was used to assess factors potentially associated with
severe ApCAP due to M. pneumoniae, C. pneumoniae and
L. pneumophila. Multivariate logistic-regression analyses
with backward stepwise method were performed to test
several models for the associations of severe ApCAP with
the potential risk factors. Here, the data are presented as
odds ratios with 95% confidence intervals (95% CI). The
level of significance was set to 0.05 for all analyses. The
above statistical procedures were performed using SPSS
version 16.0 (SPSS, Chicago, USA).
Results
Characteristics of the study subjects
The socio-demographic characteristics of 215 children
suffered from severe or non-severe ApCAP are shown in
Additional file 3. Except for age, there were no significant
differences between severe-ApCAP and non-severe ApCAP
patients with regard to gender, area of residence, kinder-
garten attendance, living conditions (air-conditioning, dust
and/or smoke pollution), or mother’s education level and
occupation.
Prevalence of severe community-acquired pneumonia
due to M. pneumoniae, C. pneumoniae and L. pneumophila
in children
As tabulated in Table 1: on the basis of PCR and serological
tests, out of 722 hospitalized children with pneumonia, 215
(29.78%) cases were positive for atypical pathogens. The
total with M. pneumoniae pneumonia was 190/215 cases
(88.37%). Among these, M. pneumoniae was detected by
PCR in 181/190 (95.26%), by ELISA-IgM in 148/190 cases
(77.89%) and by both PCR and ELISA in 139/190 (73.16%).
C. pneumoniae was detected 13/13 cases by PCR, 6/13
(46.15%) by ELISA. L. pneumophila was detected in 12/12
cases by PCR and in 11/12 cases by ELISA.
Pursuant to the criteria of PIDS and the IDS of America
for Classification of Severe pneumonia in Children, of
the 215 ApCAP cases, 97 (45.12%) were assigned to the
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as non-severe ApCAP. In both pneumonia forms, M.
pneumoniae was associated with the highest propor-
tions, for example, 86.60% of severe- ApCAP cases (84/
97) and 89.83% (106/118) of non-severe ApCAP. Two
remaining atypical pathogens appeared less frequently.
C. pneumoniae was detected in 6.19% (6/97) of severe-
ApCAP and 5.93% (7/118) in non-severe ApCAP while
L. pneumophila was found in 7.22% (7/97) of severe and
4.24% (5/118) of non-severe cases (Table 2).
In Table 3, it can be seen that among 97 severe-ApCAP
cases, ‘pure atypical pathogen’ was associated with 55.67%
(54/97) of cases, but only one atypical pathogen was re-
sponsible for most of those (51.55%, 50/97). A mixed
atypical pathogen infection was present in 4.12% (4/97).
The rates of co-infection with other pathogens (typical
bacterial pathogens, respiratory viruses, and with three
types of pathogen - atypical pathogen, typical bacterial
pathogen and respiratory virus in the same sample) in
severe-ApCAP group were 27.83% (27/97), 13.4% (13/97)
and 3.1% (3/97), respectively. In the non-severe ApCAP
group, the rates were 9.3% (11/118); 5.1% (6/118) and
0.8% (1/118) (P < 0.0001 and P < 0.008), respectively.
Streptococcus pneumoniae was the most commonly found
pathogen in co-infection cases in the severe-ApCAP group
(14/27). Co-infection with typical bacteria or a respiratory
virus increased the risk of suffering severe pneumonia
(OR = 4.62; 95% CI = 2.11-10.1; P < 0.0001 and OR = 4.07;
95% CI = 1.46-11.4; P = 0.007, respectively) (Table 3).
Table 4 shows that of the 97 severe-ApCAP cases, 66%
(64/97) occurred in children younger than 2 years, 21.65%
(21/97) in children from 2 to less than 5 years old, 11.34%
(11/97) in children from 5 to less than 10 years, and 1%
(1/97) in children 10 or older. The differences related to
age were statistically significant (P = 0.008).
Figure 1 illustrates the role of each atypical pathogen
causing severe-ApCAP in children and their distribution
by age. M. pneumoniae was the most frequently occur-
ring agent, with the highest proportion of infections in
children younger than 2 years and decreasing gradually
in frequency in older children.Table 2 Prevalence of severe community acquired













Total 215 (100) 97 (45.12) 118 (54.88)
M. pneumoniae 190 (81.4) 84 (86.60) 106 (89.83)
C. pneumoniae 13 (6.05) 6 (6.19) 7 (5.93) 0.641
L. pneumophila 12 (5.58) 7 (7.22) 5 (4.24)
Data are number (%). P-value by Fisher’s exact test.Risk factors of severe community acquired pneumonia
due to atypical pathogens in children
In Table 5, significantly associated risk factors were: age –
the younger the child, the greater the chance of severe
ApCAP (OR = 0.84; 95% CI = 0.75-0.93; P = 0.001), co-
infection with typical bacterial pathogens (OR = 4.86, 95%
CI = 2.17-10.9, P < 0.0001), co-infection with respiratory
viruses (OR = 4.36, 95% CI = 1.46-13.0, P = 0.008), respira-
tory/cardiac system malformation (OR = 14.8; 95% CI =
1.12 -196; P = 0.041) and neonatal pneumonia (OR = 11.1;
95% CI = 1.06 -116; P = 0.044). None of the other variables
investigated, including gender, nutrition status, weight at
birth, history of respiratory/cardiac system disease, asthma,
duration of illness prior to hospitalization, antibiotic usage,
and others were significantly associated with severe-ApCAP
(data not shown).
Discussion
The role of atypical pathogens in severe community-
acquired pneumonia in children
Worldwide, these three atypical pneumonia agents are each
responsible for 10% to 30% of CAP in children [11]. Among
them, M. pneumonia is the most common causative agent,
followed by C. pneumoniae and L. pneumophila. This is the
first investigation of severe ApCAP in children in Vietnam
based on molecular and serological diagnosis.
Pursuant to the criteria of PIDS and the IDS of America
for severe pneumonia, the 215 ApCAP cases in our study
were classified as severe-ApCAP (45.12%) or non-severe
ApCAP (54.88%). In both groups, M. pneumoniae accoun-
ted for the majority of infections (86.6% and 89.83%), while
C. pneumoniae and L. pneumophila were much less com-
mon (<10% for each).
According to the literature, atypical pathogens, espe-
cially M. pneumoniae and C. pneumonia, could be consid-
ered as co-infective agents in severe pneumonia [12-15],
significantly enhancing the severity of the pneumonia.
However, in our study, pure atypical pathogen infections
played an important role in severe-ApCAP, causing more
than half of severe-ApCAP cases. Co-infection with other
pathogens (typical bacterial pathogens or viruses) was
found in just under half of the cases. Among these, more
than 50% of co-infection with typical bacteria was with
Streptococcus pneumoniae.
A number of published reports [16-20] suggest that M.
pneumoniae and C. pneumoniae infections occur more
frequently in children older than two years and in
school-age children (older than five years). In our study
population, the highest proportion of general ApCAP
and of particularly severe-ApCAP cases occurred in chil-
dren younger than two years. These differences by ages
were statistically significant. In addition, M. pneumoniae
appeared to be the most important atypical pathogen in
all age groups with severe-ApCAP, compared to other
Table 3 Distribution of severe - atypical pathogen positive pneumonia according to microbiological status
Pathogens Severe ApCAP N = 97 Non-severe ApCAP N = 118 OR (95% CI) P-value
Pure atypical pathogen
- Only one atypical pathogen 50 (51.55) 94 (79.66) 1 -
- Atypical pathogen mix- infection 4 (4.12) 6 (5.08) 1.25 (0.34-4.65) 0.736
Co-infection with typically bacterial pathogen 27 (27.83) 11 (9.32) 4.62 (2.11-10.1) <0.0001
- Streptococcus pneumoniae 14 4
- Haemophilus influenzae 8 4
- Moraxella catarrhalis 1 3
- Others (S. aureus; K. pneumoniae…) 4 0
Co-infection with respiratory virus 13 (13.4) 6 (5.1) 4.07 (1.46-11.4) 0.007
- RSV 2 0
- Influenza A, B virus 3 0
- Adenovirus 4 0
- Rhinovirus 4 4
- Other virus 0 2
Co-infection with typical bacteria & respiratory virus 3 (3.1) 1 (0.8) 5.64 (0.57-55.6) 0.139
P-value obtained from logistic regression analysis.
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two years. Hence, it can be said that pure atypical patho-
gen infections, especially with M. pneumoniae appear to
play an important role in pneumonia/severe pneumonia
in young children in Vietnam.
Before this study, based on published data outside of
Vietnam [20-23], most Vietnamese pediatricians omitted
atypical pathogens, especially M. pneumoniae (causing
pneumonia) in children younger than 2 or 5 years in
their diagnosis and treatment. This study provides evi-
dence for the need to revise the existing diagnostic and
treatment criteria in Vietnam.
Risk factors related to severe community-acquired pneumonia
due to atypical pathogens in children
The results above strongly suggest that pure atypical
pathogen infections play an important role in causing
severe-ApCAP in Vietnamese children. Using appropri-
ate statistical methods, we investigated potential risk
factors for these infections. The results identified several
significant risk factors associated with severe-ApCAP:Table 4 Distribution of severe-ApCAP cases by age
Age Severe ApCAP
N = 97 (%)
Non-severe ApCAP
N = 118 (%)
1 - < 2 years 64 (65.98) 56 (47.46)
2 - < 5 years 21 (21.65) 26 (22.03)
5 - < 10 years 11 (11.34) 28 (23.73)
≥10 years 1 (1.03) 8 (6.78)
P = 0.008, Fisher exact test.age, co-infection status, respiratory/cardiac system mal-
formation, and neonatal pneumonia.
Age is generally considered as a factor associated with in-
cidence of pneumonia and mortality rate in children youn-
ger than two years. A Thai study reported that the mean
age of severe M. pneumoniae CAP was around 21 months,
in severe C. pneumoniae CAP about 49 months, and again
about 24 months in severe co-infection pneumonia [24].
However, there are reports of severe-ApCAP occurring in
healthy adolescents and adults [25,26].
In our study, the highest proportion of severe-ApCAP
infections occurred in children younger than two years;
our analysis also indicated that age is significantly associ-
ated with severe-ApCAP: the younger the child, the
more likely that the ApCAP will be severe.
In cases of co-infection in our study, it is difficult to
identify which pathogen was the first cause, especially
because the National Hospital of Pediatrics in the capital
city-Hanoi is often the last in a line of many health care
providers. At the time the patient was admitted, labora-
tory tests such as WBC, CRP often indicate an acute
bacterial infection. However, it is probable that when
more microbiological pathogens afflict the patient, the
resulting illness will be more severe [13,15].
In our study, the proportion of severe pneumonia due to
pure atypical pathogens was considerable, more than half.
Co-infection with typical bacteria was also significantly
associated with severe ApCAP. Co-infection between
M. pneumoniae and S. pneumoniae appeared most fre-
quently, more than half of the co-infections, followed
by H. influenzae and then others (Moraxella catarrhalis,
Figure 1 Distribution of severe-ApCAP cases by ages and by pathogens. Blue, red, green, and purple indicate the percentage of M.
pneumoniae (Blue square Mp), C. pneumoniae (Red square Cp), L. pneumophila (Green square Lp), and atypical pathogen mix-infection (Violet
square Mixed), respectively, detected in each age group.
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with respiratory viruses (adenovirus, rhinovirus, influenza
A, B viruses and RSV) could also enhance the severity of
pneumonia. The contribution of co-infections to the se-
verity of atypical pneumonia was assessed by multi-
variable logistic-regression analysis. Co-infection with one
of the typical bacterial pathogens could increase severe-
ApCAP cases by 4.86 times and with respiratory viruses to
4.36 times compared with pneumonia caused by only one
atypical pathogen.
Atypical pathogen co-infection was not significantly
associated with severity when compared with CAP due
to only one atypical pathogen. Co-infection with typicalTable 5 Associated factors of severe - ApCAP in multiple logis
Variables
Age Year
Co-infection status One atypical pathogen
Mixed atypical pathogens
Atypical pathogen + typical ba
Atypical pathogen + respirator
Atypical pathogen + typical ba




Odds ratio (OR) and P-values were adjusted by all variables in the table.bacterial pathogen and respiratory virus was also not sig-
nificantly associated with severe ApCAP. This was some-
what unexpected and may be due to the small number
of such samples.
Health status is one factor that could influence recov-
ery from pneumonia or severity of the illness in children.
In our study, respiratory/cardiac system malformations
and neonatal pneumonia were identified as potential risk
factors in severe ApCAP. These factors have a physical
correspondence with recurrent bronchitis or pneumon-
itis in childhood [27,28]. However, the vibration ampli-
tude of both variables was rather large, so the study
should be expanded to confirm this result.tic regression analysis with backward stepwise method




cteria 4.86 (2.17-10.9) <0.0001
y virus 4.36 (1.46-13.0) 0.008
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In general, atypical bacteria, especially M. pneumoniae and
C. pneumoniae are difficult to isolate. Serodiagnostic
methods based on IgM detection or elevated IgG titer de-
pend on the duration of the illness and on the immune re-
sponse of each individual. The development of PCR has
provided an alternative diagnostic method for etiological
agents that are difficult to culture or detect. PCR-based as-
says can provide results quickly and avoid the risk of false
negative results in conventional culture methods.
In this study, we used a combination of conventional
multiplex PCR and specific IgM antibody determination to
detect three targeted atypical pathogens (or atypical bac-
teria) and to maximize the etiological diagnosis. However,
a limitation was that we could not use real-time PCR for
detection of the atypical bacteria, which is much more sen-
sitive than conventional PCR. Due to financial limitations,
we could not expand to use other diagnostic tools such as
antigen detection test in urine for Legionella infection or
real-time PCR for detection of typical bacterial infections
in patients who had taken antibiotics prior to admission.
Conclusions
In Vietnamese children, a significant proportion of se-
vere community-acquired pneumonia was caused by the
atypical pathogens (M. pneumoniae, C. pneumoniae and
L. pneumophila). Mycoplasma pneumoniae was the most
common pathogen in severe-ApCAP.
Among severe-ApCAP cases, pure infections with
atypical pathogens accounted for more than half of the
cases. The highest rate of severe-ApCAP cases was seen
in children younger than two years. Several risk factors
were identified, among which age and co-infection with
typical bacterial pathogens or respiratory viruses were
the most significant. Respiratory/cardiac system malfor-
mation and neonatal pneumonia were also important
risk factors for severe-ApCAP in Vietnamese children.
Therefore, these pathogens, especially M. pneumoniae
should be added to the diagnostic protocols for children
with pneumonia, and to surveillance of respiratory infec-
tions, especially among younger children.
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